Moderna extends patent waiver for COVID vaccine, but only for lower-income countries

Health advocates say Moderna is narrowing its pledge not to enforce patents worldwide for the duration of the pandemic, while the company argues that, in higher-income countries, vaccine supply isn’t a barrier to access anymore.